Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
PharmAbcine and LegoChem Biosciences enter research collaboration
PharmAbcine announced a research collaboration agreement with LegoChem Biosciences. PharmAbcine will provide PMC-403 for combination research with LegoChem Biosciences’ proprietary ADC, allowing the parties to evaluate combination-therapy efficacy in solid tumors.